XML 64 R48.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue Recognition and Accounts Receivable Revenue Disaggregation (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disaggregation of Revenue [Line Items]      
Net sales $ 17,813.6 $ 11,819.9 $ 11,370.3
Brands      
Disaggregation of Revenue [Line Items]      
Net sales 10,841.3 5,234.9 5,362.1
Complex Gx and Biosimilars      
Disaggregation of Revenue [Line Items]      
Net sales 1,342.1 1,295.5 1,211.3
Generics      
Disaggregation of Revenue [Line Items]      
Net sales 5,630.2 5,289.5 4,796.9
Net sales      
Disaggregation of Revenue [Line Items]      
Net sales 17,813.6 11,819.9 11,370.3
Developed Markets | Brands      
Disaggregation of Revenue [Line Items]      
Net sales 5,759.2 3,920.7 4,199.1
Developed Markets | Complex Gx and Biosimilars      
Disaggregation of Revenue [Line Items]      
Net sales 1,241.6 1,202.6 1,127.4
Developed Markets | Generics      
Disaggregation of Revenue [Line Items]      
Net sales 3,427.9 3,387.6 2,913.5
Greater China | Brands      
Disaggregation of Revenue [Line Items]      
Net sales 2,207.8 253.9 207.6
Greater China | Complex Gx and Biosimilars      
Disaggregation of Revenue [Line Items]      
Net sales 0.2 0.7 0.4
Greater China | Generics      
Disaggregation of Revenue [Line Items]      
Net sales 4.8 5.3 6.6
JANZ | Brands      
Disaggregation of Revenue [Line Items]      
Net sales 1,197.1 617.0 533.3
JANZ | Complex Gx and Biosimilars      
Disaggregation of Revenue [Line Items]      
Net sales 46.5 42.8 23.8
JANZ | Generics      
Disaggregation of Revenue [Line Items]      
Net sales 783.8 535.5 635.4
Emerging Markets | Brands      
Disaggregation of Revenue [Line Items]      
Net sales 1,677.2 443.3 422.1
Emerging Markets | Complex Gx and Biosimilars      
Disaggregation of Revenue [Line Items]      
Net sales 53.8 49.4 59.7
Emerging Markets | Generics      
Disaggregation of Revenue [Line Items]      
Net sales 1,413.7 1,361.1 1,241.4
Operating Segments      
Disaggregation of Revenue [Line Items]      
Net sales 17,813.6 11,819.9  
Operating Segments | Developed Markets      
Disaggregation of Revenue [Line Items]      
Net sales 10,428.7 8,510.9 8,240.0
Operating Segments | Greater China      
Disaggregation of Revenue [Line Items]      
Net sales 2,212.8 259.9 214.6
Operating Segments | JANZ      
Disaggregation of Revenue [Line Items]      
Net sales 2,027.4 1,195.3 1,192.5
Operating Segments | Emerging Markets      
Disaggregation of Revenue [Line Items]      
Net sales $ 3,144.7 $ 1,853.8 $ 1,723.2